Serum Institute of India chief executive officer Adar Poonawalla. File. | Photo Credit: Kamal Narang Serum Institute of India's Chief Executive Officer Adar Poonawalla has said their Covovax vaccine will…
The Serum Institute has sought the Centre’s approval to export 32.4 lakh doses of the COVID-19 jab Covovax under the brand name Nuvaxovid to the US, which will be the…
The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18…
The subject expert committee on COVID-19 of India’s drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorisation to use Covovax among those…
The Serum Institute of India (SII) has sought permission from the country’s drug regulator to conduct Phase-3 trial to evaluate the safety and immunogenicity of its COVID-19 vaccine Covovax as…
Serum Institute of India’s coronavirus vaccine Covovax is now available for children across the country, company CEO Adar Poonawalla said on Tuesday.In a post on Twitter, he said Covovax, which…
The Standing Technical Sub-Committee of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national COVID-19 vaccination programme for children aged 12 to 17 years, sources said…
The COVID-19 Working Group of the NTAGI has recommended inclusion of the Serum Institute’s Covovax in the national vaccination programme for those aged 12 years and above, official sources said…
Covid working group of NTAGI will review this week data of Serum Institute of India’s (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19…
The Novavax vaccine is manufactured and marketed in India by SII under the brand name, Covovax. The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for…